Regression of Barrett’s Esophagus: Is There a Difference between Clinical and Surgical Treatment?
Journal: Journal of Pharmacy and Pharmacology (Vol.5, No. 12)Publication Date: 2017-12-15
Authors : Ramon Rawache Barbosa Moreira de Lima; Fernando Antônio Siqueira Pinheiro; João Odilo Gonçalves Pinto; et al;
Page : 928-933
Keywords : ;
Abstract
Objective: To evaluate the response to clinical and surgical treatment of Walter Cantídio University Hospital patients who were diagnosed with Barrett's esophagus between 2012 and 2016. Methodology: From the database analysis of Walter Cantídio University Hospital's pathology service, we identified all patients with a diagnosis of Barrett's esophagus between 2012 and 2016. We analyzed the patients' medical records and collected epidemiological and clinical data. Results: 22 patients were included in the study, 13 of whom were surgically treated and 9 were clinically treated. The regression was 33.3% in the clinical group and 30.7% in the surgical group, with no statistical difference between these two groups. Conclusions: The results show synchrony with data from the medical literature regarding the response of Barrett's esophagus to clinical and surgical treatment.
Other Latest Articles
- Trichoblastic Fibroma of the Skin Mimicking Primary or Secondary Breast Cancer
- IS There A Role of 18F-FDG PET/CT for Initial Staging of Rectal Cancer ?
- Antioxydant Activity of Some Algerian Olive Oil Samples in the Eastern and Center of Algeria
- Bioequivalence of Two Brands of Omeprazole 20 mg Gastro-Resistant Capsules in 18 Healthy Algerian Volunteers: A Pilot Study
- Fourteen Days Post-Ovariectomy Estrogens Decline Is Associated with Anxiogenic Effects on Wistar Rats
Last modified: 2022-06-30 10:11:48